Evidence map›Paper›PMID 30766774›Full record

ReviewActa pharmaceutica Sinica. B2019

Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles.

Jinsong Tao, Shing Fung Chow, Ying Zheng

Open access · diamondAbstract readReview
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 210 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Lipid nanoparticles: Composition, formulation, and application.Molecular therapy. Methods & clinical development · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jinsong TaoState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau, China.
Shing Fung ChowDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.
Ying ZhengState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Science, University of Macau, Macau, China.
University of Macau · MOUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles are considered to be a powerful approach for the delivery of poorly water-soluble drugs. One of the main challenges is developing an appropriate method for preparation of drug nanoparticles. As a simple, rapid and scalable method, the flash nanoprecipitation (FNP) has been widely used to fabricate these drug nanoparticles, including pure drug nanocrystals, polymeric micelles, polymeric nanoparticles, solid lipid nanoparticles, and polyelectrolyte complexes. This review introduces the application of FNP to produce poorly water-soluble drug nanoparticles by controllable mixing devices, such as confined impinging jets mixer (CIJM), multi-inlet vortex mixer (MIVM) and many other microfluidic mixer systems. The formation mechanisms and processes of drug nanoparticles by FNP are described in detail. Then, the controlling of supersaturation level and mixing rate during the FNP process to tailor the ultrafine drug nanoparticles as well as the influence of drugs, solvent, anti-solvent, stabilizers and temperature on the fabrication are discussed. The ultrafine and uniform nanoparticles of poorly water-soluble drug nanoparticles prepared by CIJM, MIVM and microfluidic mixer systems are reviewed briefly. We believe that the application of microfluidic mixing devices in laboratory with continuous process control and good reproducibility will be benefit for industrial formulation scale-up.

Indexed as

ACN, acetonitrileCA 320S Seb, cellulose acetate 320S sebacateCAP Adp 0.33, cellulose acetate propionate 504-0.2 adipate 0.33CAP Adp 0.85, cellulose acetate propionate adipate 0.85CFA, cefuroxime axetilCIJM, confined impinging jets mixerCMCAB, carboxymethyl cellulose acetate butyrateCTACl, cetyltrimethylammonium chlorideDex-PLLA, dextrose-poly(l-lactic acid)DMF, dimethyl formamideDMSO, dimethyl sulfoxideDSPE-PEG, distearyl phosphatidyl ethanolamine-poly(ethylene glycol)Flash nanoprecipitationFNP, flash nanoprecipitationHPC, hydroxypropyl celluloseHPMCAS, hydroxypropyl methylcellulose acetate succinateHPMC, hydroxypropyl methyl celluloseMicrofluidic mixer deviceMIVM, multi-inlet vortex mixerNaAlg, sodium alginateNaCMC, carboxymethyl cellulose sodiumNanoparticlesPAA, poly(acrylic acid)PAH, polyallylamine hydrochloridePCL, poly(ε-caprolactone)PEG-PCL, poly(ethylene glycol)-poly(ε-caprolactone)PEG-PLA, poly(ethylene glycol)-poly(lactic acid)PEG-PLGA, poly(ethylene glycol)-poly(lactic-co-glycolic acid)PEG, polyethylene glycolPEG-PS, poly(ethylene glycol)-polystyrenePEI, polyethyleneiminePEO-PDLLA, poly(ethylene oxide)-poly(d,l-lactic acid)PLA, poly(lactic acid)PLGA, poly(lactic-co-glycolic acid)P(MePEGCA-co-HDCA), poly(methoxy polyethylene glycol cyanoacrylate-co-hexadecyl cyanoacrylate)PMMA, polymethyl methacrylatePoorly water-soluble drugPSS, polyprotomine sulfatePVA, polyvinyl alcoholPVP, polyvinyl pyrrolidoneSDS, sodium dodecyl sulfonateSLS, sodium lauryl sulfateTHF, tetrahydrofuranTPGS, tocopheryl polyethylene glycol 1000 succinateε-PL, ε-polylysine

Identifiers

PMID30766774
PMCPMC6361851
OpenAlexW2900869875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.